2-phenylbenzothiazole has been researched along with gentamicin c1a in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Brunst, S; Burgers, LD; Frank, D; Fürst, R; Gobec, S; Martinelli, G; Proschak, A; Proschak, E; Rotter, MJ; Sosič, I; Weizel, L; Wichelhaus, TA | 1 |
Banerjee, S; Chhabra, M; Paira, P; Sinha, S | 1 |
2 other study(ies) available for 2-phenylbenzothiazole and gentamicin c1a
Article | Year |
---|---|
Nitroxoline and its derivatives are potent inhibitors of metallo-β-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Nitroquinolines; Recombinant Proteins; Structure-Activity Relationship | 2022 |
An efficient green synthesis of 2-arylbenzothiazole analogues as potent antibacterial and anticancer agents.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacillus subtilis; Benzothiazoles; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Escherichia coli; Green Chemistry Technology; HeLa Cells; Humans; MCF-7 Cells; Microbial Sensitivity Tests; Molecular Structure; Salmonella; Staphylococcus aureus; Structure-Activity Relationship | 2016 |